RE:RE:RE:RE:APR was acquired for 7x adj. EBITDA, VMD at 4.5x adj. EBITDASorry Longterm...I thought the conversation was about growth rates so I posted the most recent public observation from Casey Hoyt and commented that it would have to be adjusted downwards for the subsequent Omicron surge. I felt that was the same subject of growth rates that you were speaking to.
Since posting my comments, I have now read Stockfy's vitriolic attack on an earlier post about the sales by the the 13G filers. I will place Stockfy on ignore and so I won't inadvertently respond to any of his threads. I should have placed him on ignore earlier.
Reciprocally, I recommend he put me on ignore because objective comments on VieMed appear to be trigger warnings.